Related Experiment Video
Updated: Mar 2, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Resistant Starch-Capric Acid Effectively Improves Lipopolysaccharide-Induced Depressive Behavior by Protecting the
Yining Yang1, Yuanyuan Lv2, Ziqian Liang2
1College of Animal Medicine, Sichuan Agricultural University, Yaan, China.
Capric acid, delivered via resistant starch, alleviates depression-like behaviors in mice by modulating gut microbiota and neuroinflammation. This dietary intervention shows promise for managing depression by restoring gut health and brain function.
Area of Science:
- Neuroscience
- Microbiology
- Immunology
Background:
- Gut microbiota, immunity, and neuroinflammation are implicated in depression pathogenesis.
- Fatty acids possess neuroprotective properties.
Purpose of the Study:
- To investigate the effects of capric acid, delivered via resistant starch, on LPS-induced depression-like behavior in mice.
- To elucidate the underlying mechanisms, including gut microbiota modulation and neuroinflammation regulation.
Main Methods:
- Male ICR mice were administered a resistant starch-capric acid complex (RS-FA) for 50 days.
- A depression model was induced using lipopolysaccharide (LPS) injections.
- Behavioral tests (TST, OFT), biochemical analyses (TNF-α, 5-HT), histological examination, and 16S rRNA sequencing were performed.
Main Results:
- RS-FA pretreatment significantly reduced depression-like behaviors in mice.
- RS-FA decreased serum TNF-α levels and increased hippocampal 5-HT levels.
- Histological analysis showed amelioration of colonic and hippocampal damage.
- 16S rRNA analysis revealed RS-FA reversed LPS-induced gut dysbiosis, increased beneficial bacteria, and elevated short-chain fatty acid levels.
- RS-FA modulated the TLR4/NF-κB and tryptophan metabolic pathways.
Conclusions:
- Capric acid delivered via resistant starch demonstrates antidepressant-like effects.
- The mechanism involves restoring gut microbiota balance, reducing neuroinflammation, and regulating key signaling pathways.
- This approach offers a potential therapeutic strategy for depression by targeting the gut-brain axis.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

